Authors Ben-Sahra I, Dirat B, Laurent K, Puissant A, Auberger P, Budanov A, Tanti JF, Bost F
Cell death and differentiation Apr 2013
Hexavalent chromium at low concentration alters Sertoli cell barrier and connexin 43 gap junction but not claudin-11 and N-cadherin in the rat seminiferous tubule culture model.Authors Carette D, Perrard MH, Prisant N, Gilleron J, Pointis G, Segretain D, Durand P
Toxicology and applied pharmacology Apr 2013
The anti-mitotic drug griseofulvin induces apoptosis of human germ cell tumor cells through a connexin 43-dependent molecular mechanism.Authors Mauro V, Carette D, Pontier-Bres R, Dompierre J, Czerucka D, Segretain D, Gilleron J, Pointis G
Apoptosis : an international journal on programmed cell death Apr 2013
Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.Authors Chevallier D, Carette D, Segretain D, Gilleron J, Pointis G
Cellular and molecular life sciences : CMLS Apr 2013
Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.Authors Peyrade F, Re D, Ginet C, Gastaud L, Allegra M, Ballotti R, Thyss A, Zenz T, Auberger P, Robert G
Haematologica Feb 2013
Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease.Authors Vazquez-Chantada M, Gonzalez-Lahera A, Martinez-Arranz I, Garcia-Monzon C, Regueiro MM, Garcia-Rodriguez JL, Schlangen KA, Mendibil I, Rodriguez-Ezpeleta N, Lozano JJ, Banasik K, Justesen JM, Joergensen T, Witte DR, Lauritzen T, Hansen T, Pedersen O, Veyrie N, Clement K, Tordjman J, Tran A, Le Marchand-Brustel Y, Buque X, Aspichueta P, Echevarria-Uraga JJ, Martin-Duce A, Caballeria J, Gual P, Castro A, Mato JM, Martinez-Chantar ML, Aransay AM
Hepatology (Baltimore, Md.) Feb 2013
Non-alcoholic steatohepatitis in morbidly obese patients.Authors Tran A, Gual P
Clinics and research in hepatology and gastroenterology Feb 2013
Melanoma: from melanocyte to genetic alterations and clinical options.Authors Bertolotto C
Scientifica Jan 2013
How recent advances in high-risk myelodysplastic syndrome physiopathology may impact future treatments.Authors Cluzeau T, Robert G, Jacquel A, Auberger P
Current pharmaceutical design Jan 2013
Autophagy, signaling and obesity.Authors Lavallard VJ, Meijer AJ, Codogno P, Gual P
Pharmacological research Dec 2012